Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Merck, Incyte Double Down On Keytruda/Epacadostat Collaboration

DealWatch_1200x675

Related Content

Incyte and Merck Push I/O Drug Forward

Oct 14 2015

Keeping Track: Chugai Delivers Two Breakthroughs For Roche; FDA Continues To Wrestle With Opioid Regulation

Oct 07 2016

Jazz Veno-Occlusive Disease Drug Defitelio OK'd

Mar 31 2016

Vanda's Licenses CFTR Modulators From UCSF, But Not For Cystic Fibrosis

Mar 30 2017

Avillion Has Faith In Merck's Ablynx-Rejected Psoriasis Drug

Mar 30 2017

Fosun On Course To Full Indian Clearance For Gland Buyout

Mar 31 2017

Astellas Offloads Japan Product Basket To Private Equity Group

Mar 29 2017

Related Companies

Merck & Co., Inc.

Incyte Corporation

Nippon Shinyaku Co., Ltd.

Jazz Pharmaceuticals plc

Bristol Myers Squibb Company

Eli Lilly and Company

Nualtis

Orexigen Therapeutics, Inc.

Bruno Farmaceutici S.p.A.

Bausch Health Companies Inc.

Biologix FZCo

Laboratorios Farmacéuticos Rovi, S.A.

Shanghai Henlius Biotech Co. Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Vanda Pharmaceuticals, Inc.

University of California San Francisco

Avillion LLP

Merck KGaA

Ablynx N.V.

Astellas Pharma, Inc.

Additional Topics

Deals M & A Commercial BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window